Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning

被引:56
作者
Yoshihara, S
Tateishi, U
Ando, T
Kunitoh, H
Suyama, H
Onishi, Y
Tanosaki, R
Mineishi, S
机构
[1] Osaka Univ, Grad Sch Med, Dept Mol Med, Osaka 5650871, Japan
[2] Natl Canc Ctr, Stem Cell Transplant Unit, Tokyo, Japan
[3] Natl Canc Ctr, Dept Radiol, Tokyo, Japan
[4] Natl Canc Ctr, Dept Med Oncol, Tokyo, Japan
[5] Univ Michigan, Blood & Marrow Transplant Program, Ann Arbor, MI 48109 USA
关键词
bronchiolitis obliterans (BO); reduced intensity; allogeneic stem cell transplantation;
D O I
10.1038/sj.bmt.1704985
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Bronchiolitis obliterans (BO) is one of the most devastating complications after allogeneic stem cell transplantation (HSCT). However, its true pathogenesis is still to be elucidated. We conducted this study to find whether tissue damage due to high-dose chemo-radiotherapy is related to its pathogenesis. In all, 144 patients who received allogeneic HSCT between May 1999 and October 2001, and survived more than 80 days after transplant, were analyzed. Clinical course, pulmonary function tests, imaging studies including CT scan, and pathology results were reviewed. The overall incidence of BO was 9.7% (14/ 144). The cumulative incidence of BO at 2 years after transplant was 17% with myeloablative conditioning, and 2.3% with reduced intensity conditioning ( P = 0.024). Multivariate analysis showed that myeloablative conditioning was the only factor which affected the incidence of BO. Development of BO did not significantly affect the overall survival of patients. However, if they developed BO earlier than 200 days post transplant, the prognosis was significantly worse than if they developed it later than 200 days post transplant ( P = 0.003) or if they did not develop BO ( P = 0.002). Our results imply that tissue damage secondary to intensive chemo-radiotherapy may contribute to the pathogenesis of BO.
引用
收藏
页码:1195 / 1200
页数:6
相关论文
共 28 条
[1]   SMALL-AIRWAYS DISEASE IN RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS - AN ANALYSIS OF 11 CASES AND A REVIEW OF THE LITERATURE [J].
CHAN, CK ;
HYLAND, RH ;
HUTCHEON, MA ;
MINDEN, MD ;
ALEXANDER, MA ;
KOSSAKOWSKA, AE ;
URBANSKI, SJ ;
FYLES, GM ;
FRASER, IM ;
CURTIS, JE ;
MESSNER, HA .
MEDICINE, 1987, 66 (05) :327-340
[2]   Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation [J].
Childs, R ;
Chernoff, A ;
Contentin, N ;
Bahceci, E ;
Schrump, D ;
Leitman, S ;
Read, EJ ;
Tisdale, J ;
Dunbar, C ;
Linehan, WM ;
Young, NS ;
Barrett, AJ ;
Clave, E ;
Epperson, D ;
Mayo, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (11) :750-758
[3]   OBSTRUCTIVE LUNG-DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION - CLINICAL PRESENTATION AND COURSE [J].
CLARK, JG ;
CRAWFORD, SW ;
MADTES, DK ;
SULLIVAN, KM .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (05) :368-376
[4]   RISK-FACTORS FOR AIR-FLOW OBSTRUCTION IN RECIPIENTS OF BONE-MARROW TRANSPLANTS [J].
CLARK, JG ;
SCHWARTZ, DA ;
FLOURNOY, N ;
SULLIVAN, KM ;
CRAWFORD, SW ;
THOMAS, ED .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (05) :648-656
[5]  
COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713
[6]  
CURTIS DJ, 1995, BONE MARROW TRANSPL, V16, P169
[7]   Bronchiolitis obliterans in chronic graft-versus-host disease: Analysis of risk factors and treatment outcomes [J].
Dudek, AZ ;
Mahaseth, H ;
DeFor, TE ;
Weisdorf, DJ .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (10) :657-666
[8]   Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation [J].
Fukuda, T ;
Hackman, RC ;
Guthrie, KA ;
Sandmaier, BM ;
Boeckh, M ;
Maris, MB ;
Maloney, DG ;
Deeg, HJ ;
Martin, PJ ;
Storb, RF ;
Madtes, DK .
BLOOD, 2003, 102 (08) :2777-2785
[9]   CLINICAL MANIFESTATIONS OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONORS [J].
GLUCKSBERG, H ;
STORB, R ;
FEFER, A ;
BUCKNER, CD ;
NEIMAN, PE ;
CLIFT, RA ;
LERNER, KG ;
THOMAS, ED .
TRANSPLANTATION, 1974, 18 (04) :295-304
[10]  
HOLLAND HK, 1988, BLOOD, V72, P621